Lifecome Biochemistry Co

Lifecome Biochemistry Co Current Assets

The Current Assets of Lifecome Biochemistry Co (002868.SZ) as of Nov 2, 2026 is 211.59 M CNY. In the previous year, Current Assets was 230.78 M CNY — a change of -8.31% (lower).

Current Assets

211.59 MCNY

YoY

-8.31%

Last updated:

Current Assets of Lifecome Biochemistry Co is 2025 211.59 M CNY. Current Assets of Lifecome Biochemistry Co was 2024 230.78 M CNY. It decreases by -8.31% lower compared to the previous year.

The Lifecome Biochemistry Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
200.66 M CNY
Jan 1, 2019
585.91 M CNY
Jan 1, 2020
323.45 M CNY
Jan 1, 2021
247.54 M CNY
Jan 1, 2022
505.80 M CNY
Jan 1, 2023
523.73 M CNY
Jan 1, 2024
230.78 M CNY
Jan 1, 2025
211.59 M CNY
The Lifecome Biochemistry Co Current Assets history
YEARCurrent AssetsYoY
211.59 MCNY-8.31%
230.78 MCNY-55.94%
523.73 MCNY+3.55%
505.80 MCNY+104.33%
247.54 MCNY-23.47%
323.45 MCNY-44.79%
585.91 MCNY+191.99%
200.66 MCNY-59.67%
497.53 MCNY+413.79%
96.84 MCNY+4.09%
93.03 MCNY-10.31%
103.72 MCNY+77.66%
58.38 MCNY-20.99%
73.89 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifecome Biochemistry Co Stock analysis

What does Lifecome Biochemistry Co do? Lifecome Biochemistry Co., Ltd. generates revenue through the production and sale of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives, and biological pesticides. The company's product portfolio includes bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series, and Jinggangmycin series. These products are distributed domestically and internationally, targeting agricultural and veterinary sectors for animal health and feed enhancement. The firm's primary customers are domestic agricultural enterprises and international buyers seeking veterinary and feed solutions. Veterinary premixes and raw materials are key revenue drivers, alongside biological pesticides used in farming. Food and feed additives cater to the growing demand for safe and efficient animal nutrition products in both local and global markets. Lifecome Biochemistry's sales strategy focuses on leveraging its range of microbial pharmaceuticals, including probiotics and biological pesticides, to serve the agricultural industry. The company's domestic market presence is complemented by overseas distribution, ensuring a steady revenue stream from both regional and international clients. Lifecome Biochemistry Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifecome Biochemistry Co stock

Current Assets of Lifecome Biochemistry Co is 211.59 M CNY in 2025.

Current Assets of Lifecome Biochemistry Co changed from 230.78 M CNY to 211.59 M CNY, representing a -8.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Lifecome Biochemistry Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Lifecome Biochemistry Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Lifecome Biochemistry Co

All Key Metrics — Lifecome Biochemistry Co